H. D. Foley

Rhabdovirus-Based Vectors with Human Immunodeficiency Virus Type 1 (HIV-1) Envelopes Display HIV-1-Like Tropism and Target Human Dendritic Cells

J. Orenstein, R. Pomerantz, M. Schnell, 2002, Journal of Virology.

Rabies Virus-Based Vectors Expressing Human Immunodeficiency Virus Type 1 (HIV-1) Envelope Protein Induce a Strong, Cross-Reactive Cytotoxic T-Lymphocyte Response against Envelope Proteins from Different HIV-1 Isolates

I. M. Belyakov, J. Berzofsky, R. Pomerantz, 2001, Journal of Virology.

Genetic engineering of live rabies vaccines.

M. Schnell, B. Dietzschold, D. Hooper, 2001, Vaccine.

Second-Generation Rabies Virus-Based Vaccine Vectors Expressing Human Immunodeficiency Virus Type 1 Gag Have Greatly Reduced Pathogenicity but Are Highly Immunogenic

R. Pomerantz, M. Schnell, B. Dietzschold, 2003, Journal of Virology.

A recombinant rabies virus expressing vesicular stomatitis virus glycoprotein fails to protect against rabies virus infection.

M. Schnell, B. Dietzschold, H. D. Foley, 2000, Proceedings of the National Academy of Sciences of the United States of America.

Reinvestigation of the role of the rabies virus glycoprotein in viral pathogenesis using a reverse genetics approach.

K. Morimoto, M. Schnell, B. Dietzschold, 2000, Journal of neurovirology.

Both Viral Transcription and Replication Are Reduced when the Rabies Virus Nucleoprotein Is Not Phosphorylated

Z. Fu, M. Schnell, H. D. Foley, 2002, Journal of Virology.

High level expression of a human rabies virus-neutralizing monoclonal antibody by a rhabdovirus-based vector.

M. Schnell, B. Dietzschold, D. Hooper, 2001, Journal of immunological methods.

Recombinant rabies virus as potential live-viral vaccines for HIV-1.

R. Pomerantz, M. Schnell, B. Dietzschold, 2000, Proceedings of the National Academy of Sciences of the United States of America.